Impact of mother’s own milk vs. donor human milk on gut microbiota colonization in preterm infants: a systematic review
Jing Chen , Aranka J. van Wesemael , Nerissa P. Denswil , Hendrik J. Niemarkt , Johannes B. van Goudoever , Vanesa Muncan , Tim G.J. de Meij , Chris H.P. van den Akker
Microbiome Research Reports ›› 2024, Vol. 4 ›› Issue (1) : 8
Impact of mother’s own milk vs. donor human milk on gut microbiota colonization in preterm infants: a systematic review
Background: Nutritional intake in preterm infants is associated with short- and long-term outcomes. The favorable outcomes of preterm infants who predominantly receive their mother’s own milk (MOM) are thought to be mediated partly through beneficial effects on the gut microbiome. When MOM is not available, donor human milk (DHM) is recommended as the best alternative. However, DHM is less effective in preventing adverse outcomes, which may be explained by compositional differences between MOM and DHM, resulting in different microbiome development. This systematic review focuses on the effects of predominant DHM vs. MOM feeding on the gut microbiota composition in preterm infants.
Methods: A comprehensive search was conducted across MEDLINE, Embase, and Cochrane databases. Eight out of the 717 publications identified were included. Data on gut microbiota composition, alpha diversity, and taxonomic differences between DHM- and MOM-fed preterm infants were extracted and analyzed.
Results: The microbiome composition was distinct between the two feeding groups. Alpha diversity measures were lower in DHM-fed infants, particularly when preterm formula (PF) was also provided. DHM-fed infants showed higher abundances of Staphylococcaceae and Clostridiaceae, and lower abundances of Bacteroidetes and Bifidobacterium.
Conclusion: The observed gut microbiome differences in DHM-fed preterm infants have previously been linked to adverse health outcomes. This underlines the importance of increasing the awareness of MOM intake in preterm infants. Further studies should explore the mechanisms through which human milk affects health outcomes.
Fecal microbiome / premature neonate / milk bank / donor milk / breastmilk / human milk
| [1] |
Stoll BJ, Hansen NI, Bell EF, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015;314:1039-51. PMCID:PMC4787615 |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
Dharel D, Singhal N, Wood C, et al; Canadian Neonatal Network (CNN) and Canadian Preterm Birth Network (CPTBN) Investigators. Rates and determinants of mother’s own milk feeding in infants born very preterm. J Pediatr 2021;236:21-7.e4. |
| [9] |
ESPGHAN Committee on Nutrition; Arslanoglu S, Corpeleijn W, Moro G, et al. Donor human milk for preterm infants: current evidence and research directions. J Pediatr Gastroenterol Nutr 2013;57:535-42. |
| [10] |
|
| [11] |
World Health Organization. Donor human milk for low-birth-weight infants. Available from: https://www.who.int/tools/elena/interventions/donormilk-infants. [Last accessed on 20 Nov 2024] |
| [12] |
Committee on Nutrition; Section on Breastfeeding; Committee on Fetus and Newborn. Donor human milk for the high-risk infant: preparation, safety, and usage options in the United States. Pediatrics 2017;139:e20163440. |
| [13] |
Section on Breastfeeding. Breastfeeding and the use of human milk.Pediatrics2012;129:e827-41 |
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
Rozé JC, Ancel PY, Marchand-Martin L, et al; EPIFLORE Study Group. Assessment of neonatal intensive care unit practices and preterm newborn gut microbiota and 2-year neurodevelopmental outcomes. JAMA Netw Open 2020;3:e2018119. PMCID:PMC7512059 |
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
DedupEndNote (Version 1.0.0). Available online: https://github.com/globbestael/DedupEndNote. [Last accessed on 20 Nov 2024] |
| [30] |
Deeks JJ, Dinnes J, D’Amico R, et al; International Stroke Trial Collaborative Group, European Carotid Surgery Trial Collaborative Group. Evaluating non-randomised intervention studies. Health Technol Assess 2003;7:iii-x, 1-173. |
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
Dorling J, Abbott J, Berrington J, et al; SIFT Investigators Group. Controlled trial of two incremental milk-feeding rates in preterm infants. N Engl J Med 2019;381:1434-43. |
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
Rozé JC, Ancel PY, Lepage P, et al; Nutrition EPIPAGE 2 study group, EPIFLORE Study Group. Nutritional strategies and gut microbiota composition as risk factors for necrotizing enterocolitis in very-preterm infants. Am J Clin Nutr 2017;106:821-30. PMCID:PMC5573022 |
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
van den Berg JP, Westerbeek EA, Bröring-Starre T, Garssen J, van Elburg RM. Neurodevelopment of preterm infants at 24 months after neonatal supplementation of a prebiotic mix: a randomized trial.J Pediatr Gastroenterol Nutr2016;63:270-6 |
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
/
| 〈 |
|
〉 |